期刊文献+

人宫颈癌组织和Hela细胞株中SP细胞水平和生物学特性的比较研究

Comparison and analysis of side population cells in biological characteristics between human cervical cancer and Hela cells
暂未订购
导出
摘要 目的比较宫颈癌组织和Hela细胞株中多种恶性肿瘤的侧群(SP)细胞的含量和生物学特性。方法采用Altra流式细胞仪分选出宫颈癌组织原代培养6代细胞和Hela细胞株中SP细胞,检测两种细胞的表面标记和细胞周期增殖状况。结果宫颈癌组织和Hela细胞株中SP细胞水平分别为(1.62±0.48)%和(2.70±0.59)%,Hela细胞株中SP的水平明显高于宫颈癌组织,差异有统计学意义(P<0.05)。宫颈癌组织和Hela细胞株SP细胞的生物学标记(ABCG2、CD133、CD43、P63、Ki-67、MDR)表达率分别为:ABCG2(78.59±5.42)%vs.(80.17±3.60)%,CD133(51.55±6.29)%vs.(52.87±4.96)%,CD43(69.73±5.70)%vs.(70.68±5.44)%,P63(47.56±6.92)%vs.(48.06±5.28)%,Ki-67(14.69±1.69)%vs.(15.33±1.38)%,MDR(58.36±11.12)%vs.(58.24±5.32)%,表达差异均无统计学意义(P>0.05)。各细胞周期时相分布分别为:G0/G1期(94.70±1.76)%vs.(95.10±1.59)%,S期(3.25±0.99)%vs.(2.92±0.84)%,G2/M期(2.05±1.10)%vs.(1.98±0.95)%,凋亡率(4.06±0.64)%vs.(3.92±0.59)%,坏死率(1.00±0.38)%vs.(1.12±0.31)%,表达差异均无统计学意义(P>0.05)。宫颈癌组织和Hela细胞株两组SP细胞在生物学标记和细胞周期增殖状况的表达差异均无统计学意义(P>0.05)。结论宫颈癌组织和Hela细胞株中都存在SP细胞且含量不同,他们均具有肿瘤干细胞的生物学特性。 Objective To compare the proportion and biological characteristics of side population cells between human cervical cancer and Hela cells.Methods Altra flow cytometry was used to isolate SP cells from human cervical cancer and Hela cells,the cells markers and cell cycles were measured.Results The proportions of SP cells in human cervical cancer and Hela cells were(1.62±0.48)% and(2.70±0.59)%,the percentage of SP in Hela cells were significantly higher than in human cervical cancer(P〈0.05).The proportions of ABCG2,CD133,CD43,P63,Ki-67,MDR were(78.59±5.42)%vs.(80.17±3.60)%,(51.55±6.29%)vs.(52.87±4.96)%,(69.73±5.70)%vs.(70.68±5.44),(47.56±6.92)% vs.(48.06±5.28)%,(14.69±1.69)%vs.(15.33±1.38)%,(58.36±11.12)%vs.(58.24±5.32)%in human cervical cancer and Hela cells,respectively(P〉0.05).The proportions of G0/G1,S,G2/M were(94.70±1.76)%vs.(95.10±1.59)%,(3.25±0.99)%vs.(2.92±0.84)%,(2.05±1.10)%vs.(1.98±0.95)%,respectively.The proportions of apoptosis and necrosis were(4.06±0.64)%vs.(3.92±0.59)%,(1.00±0.38)%vs.(1.12±0.31)%.There were no significant differences in biological characteristics,cell cycle or cell apoptosis of the two SP cells between human cervical cancer and Hela cells(P〉0.05).Conclusion Side population cells express in human cervical cancer and Hela cells,and percentages of the two SP cells are different.The two SP cells have the characteristics of cancer stem cells.So it can be viewed as the pointcut to research the cervical cancer stem cell and supply scientific basis to identify the cervical cancer stem cell.
出处 《重庆医学》 CAS CSCD 北大核心 2014年第32期4297-4300,共4页 Chongqing medicine
基金 云南省卫生厅科学研究基金项目(2010NS084)
关键词 宫颈肿瘤 肿瘤干细胞 侧群细胞 生物学特性 uterine cervical neoplasms neoplastic stem cell side population cells biological characteristics
  • 相关文献

参考文献15

  • 1Eramo A,Lotti F,Sette G,et al. Identification and Expan-sion of the tumorigenic lung cancer stem cell population [J]. Cell Death Differ, 2008,15 (3) : 504-514.
  • 2Lobo NA, Shimono Y, Qian D et al. The biology of cancer stem cells[J]. Annu Rev Cell Dev Biol, 2007,23: 675-699.
  • 3Gupta PB, Chaffer CL, Weinberg RA. Cancer stem cells: mirageor reality[J]. Nat Med, 2009,15(9) : 1010-1012.
  • 4Reya T,Morrison SJ,Clarke MF,et al. Stem cells cancer and cancer stem cells [J]. Nature, 2001,414 (6859) : 105- 111.
  • 5宋菁华,王克芳,李斌,张军.人宫颈癌侧群细胞的分选及其生物学特性的研究[J].首都医科大学学报,2012,33(1):5-10. 被引量:12
  • 6Setoguchi T,Taga T, Kondo T. Cancer stem cells persist in many cancer cell lines. [J]. Cell Cycle,2004,3(4) :414- 415.
  • 7Karla PK, Earla R, Boddu SH, et al. Molecular expression and functional evidence of a drug efflux pump(BCRP) in human corneal epithelial cells[J]. Curt Eye Res, 2009,34 (1) :1-9.
  • 8Gao JX. Cancer stem cells:the lessons from pre-cancerous stem cells[J]. J Cell Mol Med, 2008,12 (1) : 67-96.
  • 9Nicolazzo JA,Katneni K. Drug transport across the blood brain barrier and the impact of breast cancer resistance protein (ABCG2)[J]. Curr Top Med Chem,2009,9(2) : 130-147.
  • 10Donnenberg VS, Donnenberg AD. Multiple drug resist- ance in cancer revisited: the cancer stem cell hypothesis [J]. J Clin Pharmacol, 2005,45 (8) : 872-877.

二级参考文献37

  • 1赵蕊,朱元莉,周羡梅,叶嗣懋,白若昀,耿力.子宫颈储备细胞增生与CD44v5在其细胞中的表达[J].解剖学报,2004,35(5):551-554. 被引量:9
  • 2程玺,蔡树模,李子庭,孙孟红,张太明.宫颈癌患者淋巴结CK19mRNA的检测及其临床意义[J].中国癌症杂志,2006,16(11):926-930. 被引量:13
  • 3丰有吉,沈铿.妇产科学[M].北京:人民卫生出版社,2010,7(2):60.
  • 4Chemoradiotherapy for Cervical Cancer Meta-analysis Col-laboration(CCCMAC).Reducing uncertainties about theeffects of chemoradiotherapy for cervical cancer:individualpatient data meta-analysis[J].Cochrane Database SystRev,2010(1):CD008285.
  • 5Krivtsov AV,Twomey D,Feng Z,et al.Transformationfrom committed progenitor to leukaemia stem cell initia-ted by MLL-AF9[J].Nature,2006,442(7104):818-822.
  • 6Takaishi S,Okumura T,Wang TC.Gastric cancer stemcells[J].J Clin Oncol,2008,26(17):2876-2882.
  • 7Ye F,Zhou C,Cheng Q,et al.Stem-cell-abundant proteinsNanog,Nucleostemin and Musashi1 are highly expressedin malignant cervical epithelial cells[J].BMC Cancer,2008,8:108.
  • 8Tompers DM,Foreman RK,Wang Q,et al.Foxd3 is re-quired in the trophoblast progenitor cell lineage of themouse embryo[J].Dev Biol,2005,285(1):126-137.
  • 9Babaie Y,Herwig R,Greber B,et al.Analysis of Oct4-dependent transcriptional networks regulating self-renew-al and pluripotency in human embryonic stem cells[J].Stem Cell,2007,25:500-510.
  • 10Ben-Porath I,Thomson MW,Carey VJ,et al.An embry-onic stem cell-like gene expression signature in poorlydifferentiated aggressive human tumors[J].Nat Genet,2008,40(5):499-507.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部